Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

    Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

    FromThe Lancet Oncology in conversation with

    Start listeningView podcast show

    Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

    FromThe Lancet Oncology in conversation with

    ratings:
    Length:
    16 minutes
    Released:
    Sep 29, 2020
    Format:
    Podcast episode

    Description

    Paul Sargos (Institut Bergonié, France) discusses the GETUG-AFU 17 trial and Andrew Kneebone (Royal North Shore Hospital and University of Sidney, Australia) the RAVES trial.Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
    Released:
    Sep 29, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.